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Objective: To discuss the physiological bases for using exogenously applied
electric field (EF) energy to enhance wound healing with conductive electrical
stimulation (ES) devices.
Approach: To describe the types of electrical currents that have been reported
to enhance chronic wound-healing rate and closure.
Results: Commercial ES devices that generate direct current (DC), and mono
and biphasic pulsed current waveforms represent the principal ES technolo-
gies which are reported to enhance wound healing.
Innovation: Wafer-thin, disposable ES technologies (wound dressings) that
utilize mini or micro-batteries to deliver low-level DC for wound healing and
antibacterial wound-treatment purposes are commercially available. Micro-
fluidic wound-healing chips are currently being used with greater accuracy to
investigate the EF effects on cellular electrotaxis.
Conclusion: Numerous clinical trials described in subsequent sections of this
issue have demonstrated that ES used adjunctively with standard wound care
(SWC), enhances wound healing rate faster than SWC alone.
INTRODUCTION: CLINICAL
PROBLEM
Chronic wounds represent a
major problem to patients, health-
care professionals, and the U. S.
healthcare system, involving 5.7–6.5
million patients and costing an esti-
mated 20–25 billion dollars annual-
ly.1,2 The encumbrance of treating
chronic wounds is increasing rapidly
owing to increasing healthcare costs,
an aging population, and, in the
United States and many other coun-
tries, the incidence of diabetes and
obesity is increasing precipitously.2
During the past two decades, nu-
merous wound interventions have
been developed to facilitate healing
by addressing maintenance of wound
moisture, reduction of bacterial and
nonviable tissue burdens, and man-
agement of cytokines and proteases
and by stimulating expression of
growth factors. To address these and
other needs of chronic wounds, fre-
quently standard wound care (SWC)
is employed alone or in combination
with adjunctive wound treatments
that deliver several types of bio-




The use of electric field (EF) en-
ergy applied to chronic wounds to
enhance healing has been used for
decades and is based on the existence
of endogenous wound EFs that have
been observed to direct cell migration
after injury to the integument.3 The
strength of the endogenous wound
EFs measured in animals and
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AC = alternating current
CDC=continuous direct current
DC = direct current
EF = electric field
EMF = electromagnetic field or
electromotive force
EMS=electromagnetic spectrum
ES = electrical stimulation
HVPC = high voltage pulsed
current
Hz = cycles per second (for
alternating current)
LVPC= low voltage pulsed current
MPC =monophasic pulsed
current
PC = pulsed current
pps = pulses per second (for
pulsed current)
SWC = standard wound care
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humans that have been observed to direct cell mi-
gration (electrotaxis) after wounding have been
quantified between 10 and 100lA/cm2.3,4 Research
has verified that EF energy enhances the migra-
tion of lymphocytes,5 fibroblasts,6–8 macrophages,9
and keratinocytes.10 Furthermore, in recalcitrant
wounds, it seems likely that the endogenousEFs are
askew or absent, in which case the wounds often do
not respond to SWC. When SWC alone fails to heal
chronic wounds, electrical stimulation (ES) com-
bined with SWC has been shown in several clinical
trials to enhance healing and closure.11–21 Details of
these studies are presented in subsequent sections
of this work. The information presented here will
define the ES terminology and will describe the
types of ES energy and what signal characteristics
are reported to enhance wound healing as well as
how it is delivered to wounds. Insights on what the
future holds for advances in ES wound-healing
technology will also be addressed.
Terminology of exogenous
and endogenous EFs
The terminology used to describe electric cur-
rent types, waveforms, and parameters of the ES
signals in published wound-healing clinical re-
search is often inconsistent. To appease the read-
er’s puzzlement as to how ES signal (waveform)
parameters of amplitude, frequency, and duration
influencewound treatment, currents are presented
here as adapted from a monograph published by
the Section on Clinical Electrophysiology and
Wound Management of the American Physical
Therapy Association.22
Voltage. Voltage (V) refers to the electromotive
force (EMF) which is capable of moving charged
particles (ions across cell membranes in wound
tissues) that lie between two electrodes applied to
the body. The volt is a measure of electrical pres-
sure (analogous to water pressure) and is the EMF
(electron [or ion] moving force) that is needed to
drive a current of 1A through a resistance of 1 ohm.
The relationship between voltage and amperage is
expressed as Ohm’s law, V= IR.
To produce directed current flow, there should
be a source of free electrons from the ES device,
conveyed to the patient via conductive electrodes
that are positioned to distribute the flow of a
quantity of EF energy (charge) into wound and
periwound tissues. With direct current (DC) and
monophasic pulsed current (MPC), the two elec-
trodes are polarized with regard to each other,
with one being negative (cathode) and the other
being positively charged (anode). Currents with
polarity are used for wound healing to ostensibly
replicate/activate the disturbed endogenous po-
larized current that is present after wounding of
the integument.
Basic science research has shown that endog-
enous, measurable EFs are created by trans-
membrane voltages which are found in cell
membranes and that when the epithelium of
human skin is wounded, a low resistance path-
way is created where the transepithelial poten-
tial (voltage) drives current out of the wound.
After wounding, in a moist wound environment,
there is a lateral voltage gradient of 140mV/mm
at the wound edge that decays to 10mV/mm at
500–1,000 lm from the wound edge.4 Exogenous
ES could provide a directional vector as well as a
non-vector activating mechanism to stimulate
cells involved in wound healing by enhancing
cellular motility in the wound and along the
wound edge.4
Waveforms. Waveforms are visual represen-
tations of voltage or current on an amplitude–
time plot. DC has no waveform, because once it
leaves the zero base line it continues to flow in one
direction for 1 s or longer (for as much as several
days for battery driven electrical wound dressings
that deliver micro-amperage, continuous DC)
(Fig. 1). Pulsed current (PC) waveforms are
shown as illustrations of monophasic or biphasic
electrical events that begin when the current
or voltage leaves the zero (isoelectric) baseline
in one direction, then after a finite time either
Figure 1. DC flows continuously and, therefore, has no waveform but has
distinct positive or negative polarity. DC that flows for sufficiently high
current levels for significant periods of time may cause electrochemical
injury to the skin and wound tissues. At sufficiently low lA levels, exoge-
nous DC current may be used to mimic the endogenous DC current of injury.
DC, direct current. To see this illustration in color, the reader is referred to
the web version of this article at www.liebertpub.com/wound
82 KLOTH
returns to and stops at the same baseline
(monophasic waveform) (Fig. 2A) or crosses the
baseline in the opposite direction, and ends when
the voltage or current returns again to the base-
line (biphasic waveform) (Fig. 2B, C).
Current. Current is the directed flow of elec-
trical energy or charged particles from one place
to another within matter. An electrical current
(I) is defined as the rate of flow of charged par-
ticles (electrons or ions) past a specific point in a
specific direction. Current flow in a metal wire
conductor occurs as a result of the flow of elec-
trons, whereas current flow in tissues is carried
by ions (e.g., Na + , K + , CI - ). The unit of measure
of current (I) is the ampere (A), which is defined
as the rate at which charge flows past a fixed
reference point in a conductor or mathematically
as I =C/t, where I = amps; C = coulombs; and t =
time (s). An ampere is equal to 1 coulomb per
second. Coulombs indicate the number of elec-
trons, whereas amperes indicate the rate of
electron flow. Exogenous currents delivered to
wounds that are intended to mimic the physio-
logical DC tissue currents have an order of
magnitude that may be 1,000–1,000,000 times
less than 1.0A, which places them in the milli-
ampere (mA) to microampere (lA) range. When a
unidirectional DC or PC is delivered into a
wound via electrodes, active cells that partici-
pate in the phases of healing (e.g., neutrophils,
macrophage, fibroblasts, and keratinocytes) may
migrate toward an anodal or cathodal polarized
EF (electrotaxis)5–7,9,10 or in the case of fibro-
blasts, they may be up-regulated to increase
their rate of DNA synthesis.7
Types of exogenous wound-healing currents
Two types of electrical current are usually des-
ignated as DC and defined as current that flows
continuously for 1 s or longer, and alternating
current (AC).22 However, the majority of clinical
trials that have studied the effects of ES on wound
healing have used ‘‘pulsatile’’ waveforms or pulsed
current (PC).11–21
The use of the term PC is not meant to insinuate
that there is an additional type of basic current
(there are still only two, DC and AC). Figures 1 and
2, respectively, show graphic representations of PC
and continuous DC that have been used in wound-
healing research and practice. Low-frequency AC
(1–1,000Hz [cycles per second (for alternating
current)]) has not been used with success in wound
healing clinical trials, likely because it lacks po-
larity. Therefore, sinusoidal AC for wound healing
will not be discussed here.
Direct current
Continuous direct current (CDC) is the unidi-
rectional flow of charged particles for 1 s or longer
(Fig. 1), whereas pulsed direct current flows for
1ms to 1 s as a monophasic pulsed waveform.
When delivered to wound tissues, the direction
of current flow is determined by the polarity se-
lected. Positive ions move toward the cathode, and
negative ions move toward the anode. CDC has no
pulses and, subsequently, no waveform. However,
since CDC flows for 1 s or longer, at sufficiently
high amplitudes, caustic alkaline (NaOH and H2)
and acid (HCl) products may form at the cathode
and anode, respectively, which may cause observ-
able tissue irritation. CDC studies that are applied
between 200 and 800lAhave been reported to have
positive wound-healing outcomes in seven clinical
trials, of which three are case studies23–29 Wolcott
et al.24 reported that after failure of SWC to effect
measurable progress toward healing, of 75 ische-
mic skin ulcers treated with CDC over 15 weeks,
40% closed in a mean of 9.6 weeks; while the
healing rate for all wounds was 13.4% per week.
Gault and Gatens25 used CDC and the same pro-
tocol asWolcott et al.24 to treat 100 chronic ulcers of
the integument that were deemed recalcitrant to
SWC. They indicated that 48% of these wounds
Figure 2. Pulsed electrical currents used in wound healing are either
monophasic or biphasic. (A) Examples of monophasic pulses above (or be-
low) the zero baseline. When they are above the baseline, they have positive
polarity; when they are below the baseline, they have negative polarity. (B, C)
Examples of biphasic pulses, one phase above and one phase below the zero
baseline. Their shape may be asymmetric (B) and charge unbalanced with
polarity or symmetric (C) and charge balanced without polarity. To see this
illustration in color, the reader is referred to the web version of this article at
www.liebertpub.com/wound
ELECTRICAL CURRENTS AND DEVICES FOR WOUND HEALING 83
closed in 4.7 weeks at a rate of 28.4% per week. In a
third clinical study, Carley and Wainapel26 ran-
domly assigned 30 patients with indolent skin ul-
cers below the knee or in the sacral area to
treatment with CDC or with SWC. Patients in the
treatment groups were matched by age, diagnosis,
wound size, and wound etiology. They found that
the healing rate over the 5 week study period for
the CDC group was 1.5–2.5 times faster than the
paired controls. In the fourth clinical study, Wood
and Evans27 coordinated a prospective, double-
blind, placebo trial conducted at four different ac-
ademic facilities to evaluate the effects of pulsed
DC on healing of stage II and III pressure ulcers
that had made no significant improvement to SWC
for more than 5 weeks. Unlike the previous three
CDC studies that placed one electrode on peri-
wound skin and the other on the wound, they de-
livered ES at 600lA to wounds by placing
electrodes on opposite sides of the wound*2 cm
from the wound edge. Seventy-four ulcers were
treated at the four centers. Forty-three patients
were selected for the experimental group, and 31
control subjects were assigned to the sham device
(placebo group). In the treatment group, 25 ulcers
(58%) closed in 8 weeks; whereas in the placebo
group, only 1 ulcer (3%) closed. The difference in
healing rates for the two groups was statistically
significant (p<0.0001). Despite the positive find-
ings reported from these studies, the availability of
CDC devices for wound-healing treatment has
ceased to exist in theUnited States, largely because
manufacturers are not including it as a choice in
their ESdevices. This is unfortunate, asCDCcomes
close to mimicking the physiological DC EF that
occurs after wounding of the integument and sub-
cutaneous tissues. Interestingly, a relatively new
bioelectric wound dressing that contains a minia-
ture electric circuit which delivers micro-amperage
CDC has been used with some reported success for
treating pressure and venous ulcers in the United
Kingdom28,29 (Fig. 3). Since the endogenous physi-
ological currents described earlier in this opus are
steadyDC currents that aremeasurable in humans
along the wound edge,30 exogenous micro-amper-
age CDC (Fig. 1) or MPC (Fig. 2A) appear to be the
best choices for mimicking the measurable, physi-
ological endogenous electrical signals.
Pulsed current
PC is the brief unidirectional or bidirectional
flow of electrons or ions in which each pulse is
separated by a longer off period with no current
flow. Thus, each pulse is an isolated electrical event
that is separated from each of a series or train of
pulses by a finite off time. PC is described by its
waveform, amplitude, duration, and frequency. PC
can have two waveforms: monophasic or biphasic.
Monophasic pulsed current. As shown graphi-
cally in Figures 4 and 5,31 a monophasic pulse
represents a very brief movement of electrons or
ions away from the isoelectric line, returning to the
zero line after a finite period of time ( < 1ms). MPC
waveforms described in the clinical wound-healing
literature include the rectangular or square
waveform of low-voltage MPC12–14,17,18 and the
Figure 3. The PosiFect RD DC device (BioFisica, Odiham, Hampshire,
United Kingdom and Atlanta, GA), with anode ring and cathode tab. Shown
with permission of Rafael Andino, President of Biofisica. To see this illus-
tration in color, the reader is referred to the web version of this article at
www.liebertpub.com/wound
Figure 4. Waveform of LVMPC used in several clinical trials12,17,18,20 that
reported positive healing outcomes after treatment of chronic wounds in
conjunction with standard care. LVMPC, low-voltage monophasic pulsed
current.
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twin-peaked waveform of high-voltage, mono-
phasic PC (HVPC).15,16,19–21 The duration of MPC
pulses is always less than 1 ms; therefore, unlike
CDC, which by definition flows for 1 s or longer and
frequently causes irritating pH changes on skin,
MPC does not cause pH changes and will not harm
skin or tissues.32 In addition, similar to the en-
dogenous, DC physiological EFs, both exogenous
CDC and PC have polarity while sinusoidal AC
has no polarity (charge balanced) and, therefore,
cannot mimic the physiological endogenous
DC signal.
Biphasic pulsed currents. The biphasic PC
waveform is bidirectional and consists of two pha-
ses. One phase leaves the isoelectric line, and after
a finite time returns to baseline. Typically without
delay, the second phase leaves the isoelectric line in
the opposite direction, and after a brief time re-
turns to baseline. The biphasic waveform may be
asymmetric or symmetric about the isoelectric line
(Fig. 2B, C, respectively). In the symmetric bi-
phasic waveform, the phase charges are electri-
cally equal or balanced, which is an undesirable
attribute, as there is no polarity. Asymmetric bi-
phasic waveforms may be electrically balanced or
unbalanced. The use of biphasic symmetrical
(charge balanced)33 (Fig. 2C) and asymmetrical
(charge unbalanced)13,14 (Fig. 2B) waveforms have
been described in clinical wound-healing literature
with the latter two studies reporting positive
treatment outcomes when treated with an asym-
metrical, charge unbalanced (polarized) waveform.
Thus, as previously suggested, it seems logical that
the therapeutic ES signal should come from a
polarized source of DC or PC if the intent of the
exogenous ES signal is to boost the disturbed, po-
larized, endogenous DC signal.
Electrodes: delivery of exogenous electric
signals to wound tissue
Electrodes are the conductive elements of an
electrical circuit that deliver a dosage of electrical
energy into the wound tissues. There are two
electrode placement methods that may be used to
deliver exogenous electrical currents into wound
tissues. One method utilizes a treatment electrode
of selected polarity placed in direct contact with
the wound and the return electrode placed on
intact periwound skin.11,12,15–18,20,21,23–26 (Fig. 6).
Figure 7 shows the indirect electrode placement
method in which one lead wire is bifurcated to
two electrodes of the same polarity placed bestride
the wound on intact periwound skin with the re-
turn electrode of opposite polarity on intact
skin.13,14,34–37
Both DC and PC are delivered to wound tissues
via conductive coupling.38 Thematerial make-up of
electrodes varies from carbon to hydrogel and
polymer. Some carbon electrodes can be disinfected
and reused on the same patient. For all wounds,
the shallow or deep dead space is filled with hy-
drogel or saline moist gauze, and the treatment
electrode of appropriate polarity is placed in con-
tact with the filler. This ensures that the exogenous
EF will be delivered to the wound edge and the
interior. Selection of the treatment electrode po-
larity can be based on findings from cell culture
Figure 5. Waveform of high-voltage monophasic pulsed current. Clinical
voltage levels used to deliver low levels of current to wound tissues
(*3.2lC/pulse) will not cause tissue injury from electrochemical pH
changes. (From Nelson and Currier,31 with permission.)
Figure 6. Conductively coupled monopolar electrode placement with
treatment electrode placed on a conductive saline, moist gauze or on a
wafer hydrogel sheet dressing. The return electrode is applied to intact
skin. To see this illustration in color, the reader is referred to the web
version of this article at www.liebertpub.com/wound
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electrotaxis studies or on an anecdotal (alternating
polarity) suggestion as follows:
Cathode: Enhancesmotility of cells—epithelial,4
fibroblast,6 and keratinocyte cells10
Anode: Enhances motility of cells—macro-
phage,9 neutrophil39
Alternate polarity ( + /- ) at least every week,
based on stage of healing.40
ES devices: low- and high-voltage PC
Conductively coupled ES devices are classified
according to the voltage range delivered to
treatment electrodes. Low-voltage devices deliver
CDC as well as monophasic and biphasic wave-
forms of longer durations (ls to ms) and, there-
fore, require lower driving voltages (clinically
between 20 and 35 V) (Fig. 4). All commercially
available conductively coupled ES devices except
HVPC devices fall into this category. HVPC de-
vices have a monophasic waveform with very
short phase durations which are usually < 50 ls
that require a high driving voltage (clinically
between 75 and 150 V although the maximum
voltage available is 500 V). During wound treat-
ment with HVPC, the no-current interval be-
tween successive pulses represents 99% of each
second of a treatment period; thus, the total cur-
rent per second delivered to tissue does not ex-
ceed more than 1.2–1.5 mA. If the voltage setting
during wound treatment is 100 V, the paired
pulse charge is only 3–3.5 micro-coulomb (lC).
Thus, for a pulse rate set at 100 pulses/s (pps), the
total pulse charge accumulation (dosage) does not
exceed 350 lC/s.41
Electric charge (ES wound-treatment dosage)
Electric charge is a physical property of mat-
ter (e.g., wound tissue with endogenous EF) that
causes it to experience a force when near other
electrically charged matter.42 Charge is mea-
sured in units called coulombs (C), representing
a specific quantity of electrons, that is, electri-
cally energy. The dosage or charge delivered into
wound tissues through a treatment electrode to
enhance healing is in the lC range. Several in-
dependent clinical studies that used the same low-
voltage (10–50 V) pulsed current (LVPC) device
now known as woundEL (Fig. 8) with a mono-
phasic waveform (Fig. 4) have reported wound-
healing outcomes.12,17,18,20 The stimulus parameters
used in the studies were 132ls duration, 30 mA
and 128, or 64pps (Fig. 4). The calculated wound-
healing dosage per 1h treatment per day was 250–
500lC/s, which equates to 0.89C/day at 64pps and
1.78C/day at 128pps.41
Two other independent clinical studies that
used HVPC (clinically 75–150 V) devices and
described stimulus parameters (20–60 ls; 75–150
V; and 105 pps) also reported positive wound-
healing outcomes.20,21 In these studies, the au-
thors indicated that the charge (dosage) quantities
were 342lC/s. These electrical dosages correspond
to the range of dosage values previously reported
in the four LVPC studies. The strength of the
endogenous wound EFs measured in animals and
humans that have been observed to direct cell
migration (electrotaxis) after wounding have been
Figure 8. The woundEL LVMPC device (Go¨teborg, Sweden) delivers the
same signal previously used in clinical wound-healing studies performed in
the United States and Germany that reported positive healing out-
comes.12,17,18,20 Permission granted by Molnlycke Health Care.
Figure 7. Conductively coupled bipolar treatment electrodes of opposite
polarity positioned on opposite sides of a wound. This electrode placement
approach has been utilized to deliver LVBPC in six clinical studies.13,14, 34–37
LVBPC, low voltage biphasic pulsed current. To see this illustration in
color, the reader is referred to the web version of this article at www
.liebertpub.com/wound
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measured between 10 and 100lA/cm2.3,4 When an
exogenous EF from ES is imposed on an indolent
wound EF, one may presume that the latter
would be perturbed and ostensibly restored to
normal. Using the parameters described earlier
for LVPC and HVPC, additional clinical research
is needed to confirm or refute whether the impo-
sition of the charge quantities mentioned on
wounds with languid EFs will result in enhanced
wound healing.
RESULTS
The dosage range of 250–500 lC/s represents a
small window of electrical energy that has been
shown to produce very favorable wound-healing
results in four studies which used an LVPC signal
(Fig. 4)12,17,18,20 and in two studies that used an
HVPC signal (Fig. 5).20,21 Despite the fact that the
research designs were not comparable in these six
studies, it is, nevertheless, most encouraging that
the same stimulus parameters used in the different
devices and studies yielded reproducible wound-
healing results. Clearly, further basic science and
clinical research is needed to determine whether
there is an optimal exogenous EF dosage that en-
ables the wound healing rate to exceed the out-
comes reported here.
DISCUSSION
Although the terminology and technology re-
lated to the use of ES for wound healing may
seem somewhat complex, one should realize that
the therapeutic energy described here is a part of
the intricate electromagnetic spectrum (EMS)
that represents a vast continuum of energy lev-
els employed by clinicians in several medical
fields for treatment and diagnosis of numerous
diseases or their symptoms. The energy levels
represented in the EMS range from very high
intensity, ionizing gamma rays, x-rays, and ul-
traviolet radiation to the descending intensi-
ties of non-ionizing infrared, microwave, radio
waves, and EF energies. As previously men-
tioned, endogenous EFs measured between 10
and 100 lA/cm2,3,4 in animals and humans have
been observed to direct cell migration (electro-
taxis) after wounding. While there is a dearth of
in vivo evidence of directed cell migration by
exogenous EFs, the evidence from clinical trials
supports the use of ES for the treatment of
chronic wounds as recommended by the Centers
for Medicare and Medicaid Services (CMMS).43
However, CMMS reimbursement at approxima-
tely $13 USD discourages many healthcare
practitioners from using ES in wound manage-
ment. ES for wound healing is typically per-
formed by physical therapists, as along with
several other biophysical energies, it is used in
wound healing, for example, ultrasound, low-
level laser, pulsed lavage with vacuum, positive
pneumatic compression, and pulsed radio fre-
quency energy comprise one of the pillars of
physical therapy practice. Unlike the energies
just mentioned, ES for wound healing is not a
new intervention, as positive clinical research
outcomes began appearing in the literature more
than 40 years ago.23 With steady advances in ES
technologies, combined with a plethora of com-
pelling clinical research11–21,23–29,33–37 and the
strong pressure ulcer treatment guideline rec-
ommendations of the European Pressure Ulcer
Advisory Panel and National Pressure Ulcer
Advisory Panel,44 the Registered Nurse Asso-
ciation of Canada,45 and the Paralyzed Veterans
of America,46 it seems likely that wound-care
practitioners will significantly expand the clini-
cal use of this treatment in chronic wound
management. Further strong support for this
intervention was presented by Koel47 in 2009 at
the 19th Conference of the European Wound
Management Association, where he reported on
the preliminary phase of a Cochrane review of
the effects of ES on wound healing. Twenty
randomized controlled trials (RCTs) published
between 1985 and 2008 were included in his
analysis. ES in these studies was used to treat
several wound types, including venous and ar-
terial leg ulcers, diabetic foot ulcers, pressure
ulcers, surgical wounds, and wounds of mixed
etiology. ES devices used in these studies deliv-
ered DC as well as low-voltage monophasic or
asymmetric biphasic PC and high-voltage PC
(recall that in the Results section, using the
parameters of pulse amplitude, frequency, and
duration, the charge dosage for studies that used
LVPC and HVPC signals in the range of 250–
500 lC/s has been calculated). This means that
different ES devices can produce the same elec-
trical pulse charge energy needed for healing.
This fact is supported by Koel, who presented
two summary plots from 13 of the 20 RCTs
comparing the effects of ES: one on all applied
ES types, the other on monophasic ES. In 13
studies in which all ES types or placebo ES were
delivered, 44.4% (187/421) of those who received
active ES healed, whereas only 25.9% (87/335) of
wounds in the placebo ES group healed. An
odds ratio of 2.12 (95% confidence interval [CI],
1.55–2.90) suggests a higher rate of healing in
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subjects who received ES. Koel also
found that of eight studies that com-
pared monophasic active ES or placebo
ES, 47.8% (77/161) of wounds healed
after active monophasic ES; whereas
only 17.1% (25/146) healed with placebo
ES with an odds ratio of 4.54 (95% CI,
2.65–7.79). Additional reviews of RCT
statistics from human wound-healing
ES studies reveal that there is consid-
erable evidence supporting this inter-
vention.11,48 Despite the supporting
evidence, physical therapists and other
healthcare practitioners use ES ‘‘off label,’’ be-
cause the United States Food and Drug Admin-
istration has never cleared or labeled any ES
device specifically for wound-healing purposes.
INNOVATION
In recent years, newer technologies are minia-
turized, disposable bioelectric dressing-like de-
vices with imbedded electrical circuitry that have
been cleared by healthcare regulatory agencies
for wound healing in the European Union (EU)
(Fig. 3) and for an antibacterial effect on wounds
(Fig. 9) in the United States. The former battery-
powered dressing device, Posifect (Biofisica
LLC, Atlanta, GA) delivers micro-amperage CDC.
The latter bioelectric dressing device, Procellera
(Vomaris Innovations, Chandler, AZ) is powered
by 25 micro-batteries that when activated by
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Figure 9. The antimicrobial Procellera DC device (Vomaris Innova-
tions, Chandler, AZ) contains 25 micro-batteries and a silver formulary
(permission granted by Vomaris Innovations): (A) Dry inactive dress-
ing with zero mV measured. (B) Moist active dressing showing mV
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KEY FINDINGS
 ES devices that produce DC and mono and biphasic PC waveforms
represent the primary ES technologies that are reported to enhance
wound healing.
 The electric charge or electric energy dosage that has resulted in human
wound-healing outcomes from LVPC and HVPC devices falls between 250
and 500 lC/s.
 Miniaturized and disposable bioelectric dressing devices have been
cleared by healthcare regulatory agencies for wound healing and anti-
bacterial uses in the EU and United States respectively.
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